Levofloxacina Aurovitas

Levofloxacin, the active ingredient in Levofloxacina Aurovitas, is a fluoroquinolone antibiotic presented as an intravenous solution for intravenous administration. It is used to treat a range of susceptible bacterial infections in hospitalized patients, including respiratory, urinary and skin‑soft‑tissue infections.

GNH USA supplies Levofloxacina Aurovitas as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide. The product meets EU quality standards and is manufactured under strict GMP conditions.

Levofloxacin is a fluoroquinolone antibiotic indicated for the treatment of infections caused by susceptible bacteria.

- Community‑Acquired Pneumonia: rapid bacterial eradication leading to clinical recovery. - Complicated Urinary Tract Infection: effective clearance of uropathogens. - Skin and Soft Tissue Infection: reduction of bacterial load and symptom resolution. - Intra‑Abdominal Infection: control of mixed Gram‑negative and Gram‑positive organisms. - Bacterial Prostatitis: eradication of causative pathogens with improved urinary symptoms.

Levofloxacin may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Diarrhea: loose stools, sometimes watery. - Headache: transient cranial discomfort. - Dizziness: sensation of light‑headedness. - Rash: mild skin erythema. - Elevated liver enzymes: transient increase in hepatic markers.

Serious or Rare Side Effects: - Tendon rupture: especially Achilles tendon, may occur without warning. - QT interval prolongation: risk of cardiac arrhythmias. - Clostridioides difficile infection: severe colitis. - Severe hypersensitivity: including Stevens‑Johnson syndrome. - Anaphylaxis: acute, life‑threatening allergic reaction. - Peripheral neuropathy: numbness or tingling in extremities.

Levofloxacin should be used with caution in specific clinical situations.

- Renal function: dose adjustment may be required in patients with impaired clearance. - History of tendon disorders: avoid use in individuals with prior tendon injury. - QT prolongation risk: monitor ECG in patients with cardiac arrhythmias. - Concomitant NSAIDs: increased risk of central nervous system effects. - Pregnancy and lactation: prescribe only if benefits outweigh potential risks. - Store at ambient temperature: keep in original container, protect from moisture and light.

Levofloxacin can interact with several medicines, altering efficacy or safety.

Major Interactions (Avoid): - Antacids containing aluminum or magnesium: reduce levofloxacin absorption. - Warfarin: may increase anticoagulant effect and bleeding risk. - Cyclosporine: heightened risk of nephrotoxicity.

Moderate Interactions (Monitor Closely): - Theophylline: levofloxacin may raise serum theophylline levels. - Corticosteroids: combined use increases tendon rupture risk. - Diabetes medications: possible alteration of glucose control.